All posts

DXT wins price target raise at Beacon Securities

Following the company’s AGM, Beacon Securities analyst Kirk Wilson has raised his price target on Dexterra Group (Dexterra Group Stock Quote, Chart, News, Analysts, Financials TSX:DXT).

On June 20, DXT reported that all matters at its AGM were approved by shareholders.

The analyst weighed in on where DXT is at right now.

“At its AGM yesterday, Dexterra was clear that the focus is on building the support services in both its IFM and WAFES divisions and away from the asset-based services,” he wrote. “With the pending sale of the modular business (set to close in July), DXT anticipates moving its revenue base from approximately 70%-75% today to the 85%-90% level over the next 4-5 years. The company see its EBITDA growing to $150 million in that time with 60%-65% coming from support services.”

In a research update to clients June 21, Wilson maintained his “Buy” rating but raised his price target on DXT from $7.80 to $8.10, implying a return of 59% at the time of publication.

The analyst thinks DXT will post EBITDA of $96.0-million on revenue of $1.01-billion in fiscal 2024. He expects those numbers will improve to EBITDA of $105.0-million on a topline of $1.05-billion in fiscal 2025.

Wilson says a billion in revenue with $100-million in EBITDA could soon be in the cards for Dexterra.

“Guidance from DXT to this level of financial performance is above consensus of $95 million for EBITDA and means it is confident in not only an increasing revenue base, but also the margin expansion in its IFM business. With an improved transfer of inflation and a greater impact from the recently acquired CMI Management that has margins in the 8%-10% range, DXT remains confident that IFM margins will crest 6% in H2/24. Interestingly, DXT believes it can reach the revenue/EBITDA goal without an outsized contribution from wildfire activity, which delivered $56 million of revenue in 2023 at double-digit margins. A normal wildfire season for DXT would likely see revenues 30%-40% lower than last year,” he added.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dxt
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is IMAX stock a buy? (July, 2024)

With an improving international footprint, Roth MKM analyst Eric Handler thinks there is money to be made on IMAX (IMAX… [Read More]

2 days ago

Quipt Home Medical a “Top Pick” at Ventum

With its stock on an extended slide, Ventum Capital Markets analyst Stefan Quenneville thinks there is money to be made… [Read More]

3 days ago

Sylogist wins “Top Pick” status at Ventum

Despite a strong start to the year for the stock, Ventum Capital Markets analyst Amr Ezzat remains bullish on Sylogist… [Read More]

4 days ago

WELL Health named “Top Pick” at Ventum Capital

The stock has been on fire of late, but Ventum Capital Markets analyst Rob Goff says there is more to… [Read More]

4 days ago

Ascend Wellness a Top Pick at Ventum

Want to make the second half of your year better? Pick up some shares of Ascend Wellness Holdings (Ascend Wellness… [Read More]

4 days ago

Alpha Cognition upgraded at Raymond James

With catalysts on the horizon, Raymond James analyst Rahul Sarugaser has upped his rating and price target on Alpha Cognition… [Read More]

5 days ago